Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 17, 2024

Effect of Famciclovir on EBV Activity in Patients With MS

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis
Mult. Scler. 2023 Dec 22;[EPub Ahead of Print], R Dobson, D Holden, N Vickaryous, J Bestwick, K George, T Sayali, L Bianchi, M Wafa, J Gold, G Giovannoni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading